Literature DB >> 34218014

Zwitterionic nanogels with temperature sensitivity and redox-degradability for controlled drug release.

Miao Lei1, Wenqi Zhang1, Chenxi Yi1, Luke Yan2, Yefei Tian3.   

Abstract

Zwitterionic polymers play an attractive role in the application of stealthy nanocarriers for their excellent antifouling property. Herein, a zwitterionic nanogel with temperature sensitivity and redox-responsive degradability prepared by copolymerization of N-vinylcaprolactam (VCL) and 2-(methacryloyloxy) ethyldimethyl-(3-sulfopropyl) ammonium hydroxide (DMAPS) via aqueous precipitation polymerization. The prepared nanogels own ultra-high colloidal stability and non-specific protein adsorption resistance as a result of the incorporation of zwitterionic groups. Meanwhile, they exhibit sensitive temperature-induced swelling/collapse transition in aqueous solution and excellent redox-degradability ascribed to the presence of disulfide bonds. The nanogels loaded with anticancer drug doxorubicin (DOX) exhibit low leakage of DOX under physiological conditions (merely 23.8 % within 24 h), whereas striking release amount of DOX under reducing conditions combined with elevated temperature (93.4 % within 24 h). The measurement of cell viability showed that the cytotoxicity of blank nanogels to tumor cells (HeLa cells) was negligible, while the nanogels loaded with DOX had a prominent inhibitory impact on tumor cells.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Controlled drug release; Temperature sensitivity; Zwitterionic polymer; redox-responsive

Year:  2021        PMID: 34218014     DOI: 10.1016/j.colsurfb.2021.111959

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  1 in total

Review 1.  Precipitation Polymerization: A Powerful Tool for Preparation of Uniform Polymer Particles.

Authors:  Randi Zhang; Rong Gao; Qingqiang Gou; Jingjing Lai; Xinyang Li
Journal:  Polymers (Basel)       Date:  2022-04-30       Impact factor: 4.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.